Ayurvedic Center for Collaborative Research
阿育吠陀合作研究中心
基本信息
- 批准号:6739512
- 负责人:
- 金额:$ 13.26万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2003
- 资助国家:美国
- 起止时间:2003-09-22 至 2004-07-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): Complementary and alternative medicine (CAM) usage in the U.S. is on the increase and millions of Americans suffering from chronic conditions are turning to CAM treatments, which have not been validated by Western scientific standards for safety and efficacy. Many alternative medical systems like Ayurveda, which are becoming popular in the U.S. have originated or are traditional in other countries. Ayurveda is an ancient, multifaceted, holistic medical system from India. Based on the premise that the optimal way to understand this traditional medical system is by conducting studies in its native setting, the broad goal of this research is to develop collaborative relationships among researchers from the U.S. and scientists and practitioners in India to develop an international center for CAM research in India to study Ayurveda. We have identified The Ayurvedic Trust in Coimbatore, India as the proposed center for collaboration and development. The specific aims are to: 1) Develop and consolidate long-term scientific collaborations between the Ayurvedic Trust and U.S. researchers; (2) Assess the available resources and the current needs for the Ayurvedic Trust to conduct research projects that meet current NIH scientific and regulatory standards, and gain familiarity with the Trust and its operations; (3) Refine the research design for a pilot study to form the basis of more thorough investigations in collaboration with the Ayurvedic Trust, and define the research agenda to be proposed in the subsequent International Centers for Research on Complementary and Alternative Medicine (ICRC) or other applications; (4) Initiate a plan to address the needs of the Ayurvedic Trust to facilitate the conduct of successful and ethical research, including training of personnel; (5) Develop the infrastructure to facilitate collaborative research, including developing core facilities for: 1. Information Technology Infrastructure for communications and monitoring clinical trials, and 2. Quality Assurance and Quality Control laboratory for the Ayurvedic medications; (6) Initiate a pilot study to form the basis of larger clinical trials to be proposed in the subsequent ICRC application or through other grant mechanisms.
描述(由申请人提供):补充和替代医学 (CAM) 在美国的使用正在增加,数百万患有慢性病的美国人正在转向 CAM 治疗,但这种治疗尚未经过西方科学标准的安全性和有效性验证。许多替代医疗系统,如在美国流行的阿育吠陀,都起源于其他国家或在其他国家是传统的。阿育吠陀是印度古老的、多方面的、整体的医疗体系。基于了解这种传统医学系统的最佳方式是在其本土环境中进行研究的前提,这项研究的总体目标是在美国研究人员与印度科学家和从业者之间建立合作关系,以建立一个国际中心印度的 CAM 研究旨在研究阿育吠陀。我们已确定位于印度哥印拜陀的阿育吠陀信托基金作为拟议的合作与发展中心。具体目标是: 1)发展和巩固阿育吠陀信托基金与美国研究人员之间的长期科学合作; (2) 评估阿育吠陀信托基金的可用资源和当前需求,以开展符合当前 NIH 科学和监管标准的研究项目,并熟悉该信托基金及其运营; (3) 完善试点研究的研究设计,为与阿育吠陀信托基金合作进行更彻底的调查奠定基础,并确定后续国际补充和替代医学研究中心(ICRC)或其他应用程序; (4) 启动一项计划来满足阿育吠陀信托基金的需求,以促进成功且符合道德的研究的进行,包括人员培训; (5) 开发基础设施以促进合作研究,包括开发以下核心设施: 1. 用于通信和监测临床试验的信息技术基础设施,以及 2. 阿育吠陀药物的质量保证和质量控制实验室; (6) 启动一项试点研究,为红十字国际委员会随后的申请或通过其他资助机制提出的更大规模的临床试验奠定基础。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LEANNA J STANDISH其他文献
LEANNA J STANDISH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LEANNA J STANDISH', 18)}}的其他基金
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner
通过 PSK 与多西他赛联合增强先天免疫 /C.Higano/C.Wenner
- 批准号:
8450511 - 财政年份:2011
- 资助金额:
$ 13.26万 - 项目类别:
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner
通过 PSK 与多西他赛联合增强先天免疫 /C.Higano/C.Wenner
- 批准号:
8093336 - 财政年份:2010
- 资助金额:
$ 13.26万 - 项目类别:
Enhancing innate immunity by combining PSK with docetaxel in/C.Higano/C.Wenner
通过 PSK 与多西他赛联合增强先天免疫 /C.Higano/C.Wenner
- 批准号:
8340540 - 财政年份:2010
- 资助金额:
$ 13.26万 - 项目类别:
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish
通过 HER2 靶向免疫疗法和 PSK M.Disis/L.Standish 增强免疫力
- 批准号:
8093334 - 财政年份:2010
- 资助金额:
$ 13.26万 - 项目类别:
Augmenting immunity via HER2-targeted immunotherapy and PSK M.Disis/L.Standish
通过 HER2 靶向免疫疗法和 PSK M.Disis/L.Standish 增强免疫力
- 批准号:
8340539 - 财政年份:2010
- 资助金额:
$ 13.26万 - 项目类别:
Project 3 - Phase I/II Trial of Trametes Versicolor
项目3-栓菌I/II期试验
- 批准号:
6880820 - 财政年份:2004
- 资助金额:
$ 13.26万 - 项目类别:
Training in Complementary and Alternative Medical Research
补充和替代医学研究培训
- 批准号:
8044191 - 财政年份:2002
- 资助金额:
$ 13.26万 - 项目类别:
North American Naturopathic Medical Research Consortium
北美自然疗法医学研究联盟
- 批准号:
6411956 - 财政年份:2002
- 资助金额:
$ 13.26万 - 项目类别:
Training in Complementary and Alternative Medical Research
补充和替代医学研究培训
- 批准号:
7578313 - 财政年份:2002
- 资助金额:
$ 13.26万 - 项目类别:
Training in Complementary and Alternative Medical Research
补充和替代医学研究培训
- 批准号:
7365228 - 财政年份:2002
- 资助金额:
$ 13.26万 - 项目类别:
相似国自然基金
基于新一代替代数据技术的人体心脏系统非线性动力特征研究
- 批准号:60801014
- 批准年份:2008
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Role of GDNF, ER stress and mitochondrial function in effects of acupuncture in models of parkinsonism
GDNF、ER应激和线粒体功能在针刺帕金森病模型中的作用
- 批准号:
8822479 - 财政年份:2014
- 资助金额:
$ 13.26万 - 项目类别:
Role of GDNF, ER stress and mitochondrial function in effects of acupuncture in models of parkinsonism
GDNF、ER应激和线粒体功能在针刺帕金森病模型中的作用
- 批准号:
8912366 - 财政年份:2014
- 资助金额:
$ 13.26万 - 项目类别:
Curcumin and chemoprevention of H. pylori-associated gastric carcinogenesis
姜黄素和幽门螺杆菌相关胃癌的化学预防
- 批准号:
8517590 - 财政年份:2012
- 资助金额:
$ 13.26万 - 项目类别:
Curcumin and chemoprevention of H. pylori-associated gastric carcinogenesis
姜黄素和幽门螺杆菌相关胃癌的化学预防
- 批准号:
8353168 - 财政年份:2012
- 资助金额:
$ 13.26万 - 项目类别:
STATISITICAL DESIGN, MONITORING & COORD. OF VISION CLINICAL TRIALS & EPIDEMIOLOGY
统计设计、监测
- 批准号:
9004297 - 财政年份:2011
- 资助金额:
$ 13.26万 - 项目类别: